跳到主要内容
Learn Motion
探索课程产品能力价格

下载 Learn Motion

用手机扫描二维码,下载 App。

App Store

扫码从 App Store 下载 Learn Motion打开商店页面

Google Play

扫码从 Google Play 下载 Learn Motion打开商店页面
登录
Learn Motion

How AI Is Changing Cancer Drug Discovery

1Why Cancer Drug Discovery Is So Hard2What AI Can and Cannot Do Here3Finding the Right Target4Designing Molecules with AI5Testing, Trials, and Real-World Impact6What's Next and What to Watch
Testing, Trials, and Real-World Impact

A Real Example, and What It Shows

3 / 3
The rentosertib example matters because it is the clearest case of the whole pipeline running end to end with AI as a central tool — target, molecule, testing, and eventually human trials, in about two and a half years rather than the four to six that is typical. But be careful about what that proves. One candidate reaching trials shows the approach can work; it does not show that it is faster or better in general. And for cancer specifically, the honest position is that AI-designed drugs are in testing with some promising early results, but there is not yet a widely accepted example of an approved cancer drug that came this way and changed how patients are treated.
0:00 / 0:00

Rentosertib: an AI-driven candidate that reached trials

Insilico Medicine used AI to propose a target, generate molecules against it, and select a candidate, which then entered human trials in roughly two and a half years. The disease was idiopathic pulmonary fibrosis rather than cancer, but the process followed the same stages this course has described. The milestone is that the full pipeline ran end to end with AI as a central tool and produced a molecule that reached patients in a trial.

A single candidate reaching trials is evidence that the approach can work, not proof that it is faster or better in general. The honest reading is that the method has cleared an important hurdle while the broader claim — that AI reliably shortens cancer drug discovery — remains unproven.

For cancer specifically, AI-discovered or AI-optimized drugs are in clinical testing and some have shown promising early results, but no widely accepted example of an approved, practice-changing AI-designed cancer drug exists yet.

上一页3 / 3下一页

Learn Motion

生成课程,认真学会。

运营方:Wuhan Daoyin Technology Co., Ltd.

联系我们: [email protected]
隐私政策用户服务协议

© 2026 Learn Motion